| Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry M Gianfrancesco, KL Hyrich, S Al-Adely, L Carmona, MI Danila, L Gossec, ... Annals of the rheumatic diseases 79 (7), 859-866, 2020 | 1179 | 2020 |
| Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ... Annals of the rheumatic diseases 80 (7), 930-942, 2021 | 652 | 2021 |
| Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort GJ Pons‐Estel, GS Alarcón, G McGwin Jr, MI Danila, J Zhang, HM Bastian, ... Arthritis Care & Research: Official Journal of the American College of …, 2009 | 307 | 2009 |
| Annotating the human genome with Disease Ontology JD Osborne, J Flatow, M Holko, SM Lin, WA Kibbe, L Zhu, MI Danila, ... BMC genomics 10, 1-8, 2009 | 301 | 2009 |
| Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort MI Danila, GJ Pons-Estel, J Zhang, LM Vila, JD Reveille, GS Alarcon Rheumatology 48 (5), 542-545, 2009 | 264 | 2009 |
| The genomic sequence of ectromelia virus, the causative agent of mousepox N Chen, MI Danila, Z Feng, RML Buller, C Wang, X Han, EJ Lefkowitz, ... Virology 317 (1), 165-186, 2003 | 179 | 2003 |
| IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation E Zumaquero, SL Stone, CD Scharer, SA Jenks, A Nellore, B Mousseau, ... Elife 8, e41641, 2019 | 140 | 2019 |
| COVID-19 Global Rheumatology Alliance. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology … M Gianfrancesco, KL Hyrich, S Al-Adely, L Carmona, MI Danila, L Gossec, ... Ann Rheum Dis 79 (7), 859-866, 2020 | 139 | 2020 |
| Bisphosphonate‐associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report P Narongroeknawin, MI Danila, LG Humphreys Jr, A Barasch, JR Curtis Special Care in Dentistry 30 (2), 77-82, 2010 | 113 | 2010 |
| Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand? KI Halilova, EE Brown, SL Morgan, SL Bridges Jr, MH Hwang, DK Arnett, ... International journal of rheumatology 2012 (1), 978396, 2012 | 89 | 2012 |
| A REDCap-based model for electronic consent (eConsent): moving toward a more personalized consent CE Lawrence, L Dunkel, M McEver, T Israel, R Taylor, G Chiriboga, ... Journal of clinical and translational science 4 (4), 345-353, 2020 | 87 | 2020 |
| Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled … JJ Solomon, SK Danoff, FA Woodhead, S Hurwitz, R Maurer, I Glaspole, ... The Lancet Respiratory Medicine 11 (1), 87-96, 2023 | 85 | 2023 |
| Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic MD George, S Venkatachalam, S Banerjee, JF Baker, PA Merkel, ... The Journal of rheumatology 48 (4), 603-607, 2021 | 75 | 2021 |
| Age and fecal microbial strain-specific differences in patients with spondyloarthritis ML Stoll, PF Weiss, JE Weiss, PA Nigrovic, BS Edelheit, SL Bridges, ... Arthritis research & therapy 20, 1-10, 2018 | 71 | 2018 |
| Advancing the science and practice of medication adherence MJ Stirratt, JR Curtis, MI Danila, R Hansen, MJ Miller, CA Gakumo Journal of general internal medicine 33, 216-222, 2018 | 70 | 2018 |
| Genetic influences on susceptibility to rheumatoid arthritis in African-Americans VA Laufer, HK Tiwari, RJ Reynolds, MI Danila, J Wang, JC Edberg, ... Human Molecular Genetics 28 (5), 858-874, 2019 | 65 | 2019 |
| Biologics and heart failure in rheumatoid arthritis: are we any wiser? MI Danila, NM Patkar, JR Curtis, KG Saag, GG Teng Current opinion in rheumatology 20 (3), 327-333, 2008 | 60 | 2008 |
| Antirheumatic disease therapies for the treatment of COVID‐19: a systematic review and meta‐analysis M Putman, YPE Chock, H Tam, AHJ Kim, SE Sattui, F Berenbaum, ... Arthritis & Rheumatology 73 (1), 36-47, 2021 | 58 | 2021 |
| Osteoporosis in 10 years time: a glimpse into the future of osteoporosis G Adami, A Fassio, D Gatti, O Viapiana, C Benini, MI Danila, KG Saag, ... Therapeutic advances in musculoskeletal disease 14, 1759720X221083541, 2022 | 52 | 2022 |
| Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis TW Muskardin, P Vashisht, JM Dorschner, MA Jensen, BS Chrabot, ... Annals of the rheumatic diseases 75 (10), 1757-1762, 2016 | 50 | 2016 |
Jeffrey CurtisProfessor of Medicine, UAB在 uab.edu 的电子邮件经过验证
